SG11201502753YA - Methods and compositions for treatment of retinal degeneration - Google Patents

Methods and compositions for treatment of retinal degeneration

Info

Publication number
SG11201502753YA
SG11201502753YA SG11201502753YA SG11201502753YA SG11201502753YA SG 11201502753Y A SG11201502753Y A SG 11201502753YA SG 11201502753Y A SG11201502753Y A SG 11201502753YA SG 11201502753Y A SG11201502753Y A SG 11201502753YA SG 11201502753Y A SG11201502753Y A SG 11201502753YA
Authority
SG
Singapore
Prior art keywords
compositions
treatment
methods
retinal degeneration
retinal
Prior art date
Application number
SG11201502753YA
Inventor
Casey C Case
Toru Kawanishi
Kuno Noriyuki
Original Assignee
Sanbio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanbio Inc filed Critical Sanbio Inc
Publication of SG11201502753YA publication Critical patent/SG11201502753YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201502753YA 2012-10-09 2013-03-13 Methods and compositions for treatment of retinal degeneration SG11201502753YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261711665P 2012-10-09 2012-10-09
PCT/US2013/030983 WO2014058464A1 (en) 2012-10-09 2013-03-13 Methods and compositions for treatment of retinal degeneration

Publications (1)

Publication Number Publication Date
SG11201502753YA true SG11201502753YA (en) 2015-05-28

Family

ID=48040427

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201502753YA SG11201502753YA (en) 2012-10-09 2013-03-13 Methods and compositions for treatment of retinal degeneration
SG10201607176TA SG10201607176TA (en) 2012-10-09 2013-03-13 Methods And Compositions For Treatment Of Retinal Degeneration

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201607176TA SG10201607176TA (en) 2012-10-09 2013-03-13 Methods And Compositions For Treatment Of Retinal Degeneration

Country Status (11)

Country Link
US (2) US9326999B2 (en)
EP (1) EP2906293B1 (en)
JP (2) JP6267713B2 (en)
KR (2) KR101906756B1 (en)
CN (1) CN104797264A (en)
AU (2) AU2013330433B2 (en)
CA (1) CA2885414C (en)
HK (1) HK1208371A1 (en)
IL (1) IL237772B (en)
SG (2) SG11201502753YA (en)
WO (1) WO2014058464A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101906756B1 (en) 2012-10-09 2018-12-05 산바이오 인코포레이티드 Methods and compositions for treatment of retinal degeneration
KR102248804B1 (en) 2014-03-12 2021-05-11 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the cns
US10519237B2 (en) 2014-03-12 2019-12-31 Yeda Research And Development Co. Ltd Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
US10618963B2 (en) 2014-03-12 2020-04-14 Yeda Research And Development Co. Ltd Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
CN109895489A (en) 2014-07-31 2019-06-18 尤尼林有限公司 Manufacture the method and apparatus and floor covering product of floor covering product
WO2018102174A1 (en) * 2016-12-01 2018-06-07 Janssen Biotech, Inc. Treatment of retinal degeneration using progenitor cells
EP3548114A4 (en) 2016-12-28 2020-07-15 SanBio, Inc. Cell delivery system and methods of operation thereof
JP7233375B2 (en) 2017-03-15 2023-03-06 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Methods of treating lysosomal disorders
CN107519491B (en) * 2017-09-04 2020-08-25 无锡市人民医院 Use of COPB2 inhibitor
WO2020210218A1 (en) * 2019-04-12 2020-10-15 The Regents Of The University Of California Methods for treating inherited eye defects

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002247847A1 (en) * 2001-04-09 2002-10-21 Lorantis Limited Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways
JP3886346B2 (en) 2001-06-22 2007-02-28 サンバイオ，インコーポレイティド Pharmaceutical composition for nerve regeneration comprising bone marrow stromal cell-derived Schwann cells
JP2004536877A (en) * 2001-07-25 2004-12-09 ロランティス リミテッド Notch signaling modulators for immunotherapy
DK1479767T3 (en) 2002-02-06 2013-11-25 Sanbio Inc Method of differentiating / inducing bone marrow to nerve cells by transferring Notch gene
GB0300428D0 (en) * 2003-01-09 2003-02-05 Lorantis Ltd Medical treatment
PL1737950T3 (en) 2004-04-12 2012-02-29 Sanbio Inc Cells exhibiting neuronal progenitor cell characteristics
DK1855700T3 (en) 2005-03-07 2014-01-13 Sanbio Inc Use of neuronal precursor cells to treat lesions of the central nervous system
CA2677679A1 (en) * 2007-02-12 2008-08-21 Anthrogenesis Corporation Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations
WO2008102460A1 (en) 2007-02-23 2008-08-28 Sanbio Inc. Transplantation of bone marrow stromal cell-induced neural stem cells for promoting fuctional recovery after spinal cord injury
CN101801396B (en) * 2007-08-15 2013-10-30 桑比欧公司 Methods and compositions for treating neural degeneration
WO2009073178A1 (en) 2007-12-03 2009-06-11 Sanbio, Inc. Extracellular matrix from pluripotent cells
DK2222839T3 (en) 2007-12-03 2015-12-21 Sanbio Inc Methods and compositions for modulating differentiation of pluripotent cells
ES2582559T3 (en) * 2007-12-06 2016-09-13 Inserm - Institut National De La Santé Et De La Recherche Médicale Trophic factor for the treatment of degenerative diseases of the retina
PL2274430T3 (en) 2008-04-30 2017-09-29 Sanbio Inc Neural regenerating cells with alterations in dna methylation
US8677056B2 (en) 2008-07-01 2014-03-18 Lsi Corporation Methods and apparatus for interfacing between a flash memory controller and a flash memory array
MX2011000233A (en) * 2008-07-08 2011-05-19 Oncomed Pharm Inc Notch1 receptor binding agents and methods of use thereof.
US20110002897A1 (en) * 2009-06-11 2011-01-06 Burnham Institute For Medical Research Directed differentiation of stem cells
EP3669933B1 (en) * 2010-02-26 2022-08-31 Cornell University Retina prosthesis
US11739366B2 (en) * 2010-07-23 2023-08-29 Astellas Institute For Regenerative Medicine Methods for detection of rare subpopulations of cells and highly purified compositions of cells
WO2012034101A2 (en) * 2010-09-09 2012-03-15 The Regents Of The University Of California Expandable cell source of neuronal stem cell populations and methods for obtaining and using them
CN103547275B (en) 2011-04-06 2016-12-28 桑比欧公司 For regulating the method and composition of periphery immunologic function
US20120263681A1 (en) 2011-04-12 2012-10-18 Fujifilm Corporation Composition comprising cell and biocompatible polymer
US20130210000A1 (en) 2011-08-19 2013-08-15 Irina Aizman Neurogenic and gliogenic factors and assays therefor
EP2806881A1 (en) 2012-01-27 2014-12-03 SanBio, Inc. Methods and compositions for modulating angiogenesis and vasculogenesis
US9828593B2 (en) 2012-05-16 2017-11-28 Sanbio, Inc. Methods and compositions for treatment of traumatic brain injury and for modulation of migration of neurogenic cells
US20140219976A1 (en) 2012-10-09 2014-08-07 Sanbio, Inc. Methods and compositions for treatment of retinal degeneration
KR101906756B1 (en) 2012-10-09 2018-12-05 산바이오 인코포레이티드 Methods and compositions for treatment of retinal degeneration

Also Published As

Publication number Publication date
EP2906293A1 (en) 2015-08-19
CN104797264A (en) 2015-07-22
JP6267713B2 (en) 2018-01-24
IL237772B (en) 2019-10-31
CA2885414A1 (en) 2014-04-17
EP2906293B1 (en) 2018-12-12
JP2015533122A (en) 2015-11-19
US20140099291A1 (en) 2014-04-10
US20160271181A1 (en) 2016-09-22
US9326999B2 (en) 2016-05-03
HK1208371A1 (en) 2016-03-04
SG10201607176TA (en) 2016-10-28
JP6297648B2 (en) 2018-03-20
AU2013330433A1 (en) 2015-04-02
JP2016210813A (en) 2016-12-15
KR101906756B1 (en) 2018-12-05
AU2013330433B2 (en) 2016-06-16
AU2016213752A1 (en) 2016-08-25
KR20170133515A (en) 2017-12-05
IL237772A0 (en) 2015-05-31
KR20150075082A (en) 2015-07-02
WO2014058464A1 (en) 2014-04-17
CA2885414C (en) 2018-05-01
US9855299B2 (en) 2018-01-02
AU2016213752B2 (en) 2017-11-23

Similar Documents

Publication Publication Date Title
IL260585B (en) Compositions and methods for treating retinal diseases
HK1210502A1 (en) Methods and compositions for treatment of a genetic condition
HK1210968A1 (en) Compositions and treatment for eye diseases and disorders
HK1208371A1 (en) Methods and compositions for treatment of retinal degeneration
EP2771030A4 (en) Compositions and methods for treatment of proteinopathies
EP2776567A4 (en) Compositions and methods for treatment of cytomegalovirus
SG2014008080A (en) Methods of treatment of retinal degeneration diseases
EP2819687A4 (en) Compositions and methods for treatment of peripheral vascular disease
DK3292875T3 (en) Compositions and methods for treating diseases
EP2691529A4 (en) Methods and compositions for treating brain diseases
PL2814463T3 (en) Ophthalmic pharmaceutical compositions and methods of making and using same
IL234606B (en) Novel methods and composition for treatment of disease
EP2755668A4 (en) Hyr1-derived compositions and methods of treatment using same
EP2670243A4 (en) Compositions and methods for treatment of glaucoma
EP2879495A4 (en) Compositions and methods for treatment of neuropsychological deficits
EP2928456A4 (en) Methods and compositions for treatment of cancer
EP2800568A4 (en) Compositions, methods of use, and methods of treatment
EP2825184A4 (en) Compositions and methods for treatment of pain
EP3003341A4 (en) Compositions and methods for treatment of retinal degenerative diseases
AU2012902296A0 (en) Compositions for Therapy and Methods of Treatment